() () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () ()

News

Organigram Announces Letter of Intent for Strategic Investment in Hyasynth Biologicals Inc.

Organigram Holdings Inc. (TSX VENTURE: OGI) (OTCQB: OGRMF) ("Organigram"), a leading licensed producer of medical marijuana based in Moncton, New Brunswick, is pleased to announce that it has entered into a letter of intent with Hyasynth Biologicals, Inc. ("Hyasynth") whereby Organigram proposes to make a strategic investment in Hyasynth.  Additionally, the non-binding letter of intent contemplates Organigram entering into an off-take agreement with Hyasynth whereby Organigram can purchase a pre-defined quantity of a range of cannabinoids or cannabinoid related production from Hyasynth on terms set forth in such agreement.
Read more

Speakeasy closes first tranche $4.9 million financing

Speakeasy Cannabis Club Ltd. (CSE: EASY) (Frankfurt: 39H) (the "Company" or "SpeakEasy") announces it has closed the first tranche of its non-brokered private placement (the "Private Placement") of 4,900,000 Units ("Units") at a price of $1.00 per Unit for gross proceeds of $4,900,000. Each Unit will be comprised of one common share of the Issuer (a "Share") and one common share purchase warrant of the Issuer (each whole warrant, a "Warrant").
Read more
Get $50 in free trades.